Kamlakar Tripathi MD DM DNB MNAMS (Nephrology) FICP FFRSSDI FISH FUPDA FIAMS FRCP (Edinburgh)Former Professor and Head, Department of Medicine, Banaras Hindu University Varanasi, Uttar Pradesh, India; Padma Shri Awardee 2022Banshi Saboo MD PhD DSc FRCP MNAMS Fellow American College of Endocrinology (FACE) Fellow International College of Nutrition (FICN, Canada) Diabetologist and Metabolic Physician DIACARE (Diabetes Care and Hormone Clinic), Ahmedabad, Gujarat, India; Honorary Secretary, Diabetes IndiaAmit Gupta DNB (General Medicine) MNAMS FACE FICP FRCP (Glasgow, Edinburgh) FACP FRSSDI F-DiabJoint Secretary, Diabetes India; Diabetologist and Metabolic Physican, Medical Director, Centre for Diabetes Care, Greater Noida, Uttar Pradesh, India

• 1. History of Diabetes2. Diagnosis and Classification of Diabetes 3. Clustering of Type 2 Diabetes 4. Epidemiology of Type 2 Diabetes 5. Epidemiology of Type 1 Diabetes 6. The Management of Type 1 Diabetes in Adults 7. Epidemiology of Gestational Diabetes Mellitus 8. Anatomy of Beta Cell: In Health and Disease 9. Carbohydrate, Lipids, Protein–Normal Metabolism 10. Role of Liver in Glucose Metabolism (MASLD/MASH) 11. Insulin Structure, Biosynthesis, Secretion, and Action of Insulin 12. Biological Effects of C‐peptide and Proinsulin 13. Biosynthesis, Secretion, and Action of Glucagon 14. Associated and Causative Genes or Variants in Diabetes 15. Autoimmunity and Diabetes 16. Molecular Pathogenesis of Type 2 Diabetes 17. Gut Microbiome and Diabetes: An Untold Story 18. Monogenic Diabetes 19. Insulin Intensification 20. Endocrine Disease and Diabetes 21. Pancreatic Disease and Diabetes 22. Hereditary and Acquired Syndrome in Diabetes 23. Stress-induced Diabetes 24. Interplay of Neuroendocrine and Autonomic Factors in Diabetes Mellitus 25. Type 2 Diabetes: “Thrifty Genotype” or a “Thrifty Phenotype”?26. Sarcopenia and Diabetes: A Lethal Conjunction 27. Weight Modulation with Glucose Lowering Drugs 28. Bariatric Surgery 29. Self-monitoring of Blood Glucose 30. Continuous Glucose Monitoring: A Comprehensive Guide towards Better Understanding CGM and AGP 31. Long Term Glycemic Monitoring 32. Monitoring Microvascular Complications 33. Monitoring Macrovascular Complications of Diabetes 34. Nuclear Medicine and Diabetes 35. Noninvasive Glucose Monitoring 36. Therapeutic Patient Education 37. Effect of Exercise and Yoga 38. Dietary Management 39. Stress in Diabetes and Its Management 40. Nutraceuticals in Diabetes 41. Sulfonylureas 42. Re-emerging Role of Sulfonylureas in Alpha-Beta Cell Preservation 43. Meglitinides 44. Metformin45. Thiazolidinedione as PPAR Agonist 46. Alpha-glucosidase Inhibitors 47. DPP-4 Inhibitors 48. Glucagon-like Peptide-1 Receptor Agonist49. SGLT-2 Inhibitors50. Initial Combination Therapy for Management of Glycemia in Adults with New-onset Type 2 Diabetes Mellitus 51. Insulin Taxonomy 52. Insulin Initiation: Choosing the Regimen 53. Combining Insulin with Oral Antidiabetic Agents 54. GLP-1 RA and Insulin Combination 55. Insulin Therapy in Renal and Hepatic Diseases 56. Insulin Technique 57. Noninjectable Insulins 58. Insulin Analogues 59. Future Generations of Insulin 60. Epidemiology of Diabetic Microvascular Complications and their Relation with Glycemic Control61. Advances in Insulin Therapy and Insulin Futures 62. Pathogenesis and Management of Diabetes Eye Disease Including Nonretinal Ocular Complications 63. Future Prospects in Screening for Diabetic Retinopathy 64. Management of Diabetic Neuropathy 65. Diabetic Autonomic Neuropathy 66. Pathogenesis and Management of Diabetic Nephropathy67. Nondiabetic Kidney Disease in Diabetes Mellitus 68. Management of Diabetes in End-stage Renal Disease 69. Epidemiology of Macrovascular Disease and Effect of Intensive Diabetes Control on Macrovascular Events 70. Cardiometabolic Risk 71. Insulin Resistance, Metabolic Stress, Endothelial Dysfunction, and Atherosclerosis 72. Lipid Disorders in Diabetes 73. Hypertension in Diabetes74. Diabetes and Coronary Artery Disease 75. Diabetes and Heart Failure 76. Diabetes and Cerebrovascular Disease 77. Use of Oral Antithrombotic in Diabetic Macrovascular Complications 78. Diabetes and Peripheral Vascular Disease 79. Oral Cavity and Diabetes 80. Diabetic Hepatopathy, Steatohepatitis and Gastrointestinal Disorders in Diabetes 81. Rheumatological Manifestations in Diabetes 82. Diabetes and Cancer: Direct Link and Indirect Link Through Oral Anti-diabetic Drugs 83. Anemia in Diabetes 84. Diabetes and Sexual Dysfunctions 85. Polycystic Ovary Syndrome and Diabetes 86. Skin Disorders in Diabetes 87. Epidemiology of Diabetes and Multimorbidity 88. Differences in Cardiac and Renal Protection with SGLT-2 Inhibitors 89. Hypoglycaemia 90. Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State 91. Glycemic Monitoring during Labor 92. Perioperative Management of Hyperglycemia 93. Management of In-hospital Hyperglycemia 94. Tuberculosis and Diabetes Mellitus 95. HIV/AIDS and Diabetes 96. Urogenital Infections in Diabetes 97. Other Infections in Diabetes 98. Surgical Anatomy and Biomechanics of Foot99. Epidemiology and Pathogenesis of Diabetic Foot Ulcer 100. Clinical Approach to a Patient of Diabetic Foot and Evaluation Technique 101. Surgical Management of Diabetic Foot 102. Management of Diabetic Foot Infections 103. Day-to-day Foot Care in Diabetes 104. Preconception Management of Diabetes 105. Pharmacological Therapy in Diabetes Mellitus 106. Obstetrical Management of Gestational Diabetes Mellitus 107. Postpartum Management of Diabetes 108. Diabetes in Adolescents 109. Hypogonadotropic: Hypogonadism in Men with Type 2 Diabetes Mellitus 110. Diabetes and Menopause 111. Diabetes in Women 112. Diabetes in Elderly 113. Use of Artificial Intelligence in Diabetes Space Today 114. Ramadan Specific Diabetes Education 115. Nonpharmacological Therapy in Ramadan 116. Oral Glucose-lowering Therapy in Ramadan 117. Insulin Therapy in Ramadan 118. Continuous Subcutaneous Insulin Infusion Pump 119. Immunotherapy for Diabetes 120. Islet Cell Transplant and Pancreatic Transplantation 121. Gene Therapy versus Stem Cell Therapy in Management of Diabetes Mellitus 122. Role of Electronic Medical Records, Gadgets, Social Media, and Mobile App in Diabetes Care 123. Clinical Inertia 124. Diabetes Distress 125. Diabetes and Mental Health 126. Anxiety and Depressive Disorders in Diabetes 127. Eating Disorders and Diabetes 128. Drug Addiction and Diabetes 129. Employment and Diabetes 130. Travel and Diabetes 131. Sports and Diabetes 132. Marriage, Sexuality and Diabetes 133. Diabetes Advocacy: A Plea for Patients 134. Prevention of Diabetes 135. Global Organizations: Focus on Diabetes 136. Indian National Programmes and Policy Decisions for Diabetes137. National List of Essential Medicines and Accessibility to Antidiabetic Drug in India: A Review 138. Economic Burden of Diabetes 139. Health Insurance and Diabetes 140. Health Economic of Anti-diabetic Therapy 141. Affordable Diabetes Care: Indian Public Health Standards 142. Biosimilars and Generics 143. Parent and Patient Education in Type 1 Diabetes 144. Diabetes Self-management: A Compilation of the Current Evidence and Practices 145. Motivational Interviewing in Diabetes Care146. Religion as a Motivator for Diabetes Care 147. Novel Subgroups and Clustering in Diabetes 148. Management of Diabetes during Disaster 149. Diabetes Reversibility 150. Role of Imaging in Management of Complications Associated with Diabetes Mellitus Patients